title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Tuesday,20220315T163235,https://www.benzinga.com/news/22/03/26148458/stocks-that-hit-52-week-lows-on-tuesday,VTGN,0.00539,Neutral,-0.010128
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,VTGN,0.005366,Neutral,-0.005659
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday,20220725T083855,https://www.benzinga.com/news/22/07/28182325/this-technology-stock-surged-235-here-are-77-biggest-movers-from-friday,VTGN,0.057559,Neutral,-0.135209
"Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session - AERWINS Technologies  ( NASDAQ:AWIN ) , Arch Resources  ( NYSE:ARCH ) ",20231002T170027,https://www.benzinga.com/news/23/10/35037344/why-intelligent-bio-solutions-shares-are-trading-lower-by-around-55-here-are-other-stocks-moving-in,VTGN,0.113062,Somewhat-Bearish,-0.208825
Stocks That Hit 52-Week Lows On Tuesday,20220524T161351,https://www.benzinga.com/markets/options/22/05/27375519/52-weeks-high-and-low-article,VTGN,0.010175,Neutral,-0.006708
Stocks That Hit 52-Week Lows On Monday,20220314T161153,https://www.benzinga.com/news/22/03/26125409/stocks-that-hit-52-week-lows-on-monday,VTGN,0.003772,Neutral,0.013657
"Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Akso Health Group  ( NASDAQ:AHG ) , AGBA Group Holding  ( NASDAQ:AGBA ) ",20231017T121251,https://www.benzinga.com/news/23/10/35284666/why-vistagen-therapeutics-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket,VTGN,0.152499,Neutral,0.107579
"VistaGen Therapeutics, Inc.  ( VTGN )  Reports Q2 Loss, Misses Revenue Estimates",20241108T003004,https://www.zacks.com/stock/news/2367061/vistagen-therapeutics-inc-vtgn-reports-q2-loss-misses-revenue-estimates,VTGN,0.399204,Neutral,0.046509
"Zymeworks Inc.  ( ZYME )  Reports Q3 Loss, Lags Revenue Estimates",20241031T212010,https://www.zacks.com/stock/news/2362119/zymeworks-inc-zyme-reports-q3-loss-lags-revenue-estimates,VTGN,0.211191,Neutral,0.0
Biogen Inc.  ( BIIB )  Q3 Earnings and Revenues Surpass Estimates,20241030T120506,https://www.zacks.com/stock/news/2360294/biogen-inc-biib-q3-earnings-and-revenues-surpass-estimates,VTGN,0.20997,Neutral,0.0
VistaGen Therapeutics  ( VTGN )  Upgraded to Buy: Here's What You Should Know,20241011T160011,https://www.zacks.com/stock/news/2349441/vistagen-therapeutics-vtgn-upgraded-to-buy-heres-what-you-should-know,VTGN,0.369685,Bullish,0.381069
All You Need to Know About VistaGen Therapeutics Rating Upgrade to Buy - Vistagen Therapeutics  ( NASDAQ:VTGN ) ,20240906T195222,https://www.benzinga.com/general/biotech/24/09/40753902/all-you-need-to-know-about-vistagen-therapeutics-rating-upgrade-to-buy,VTGN,0.339356,Somewhat-Bullish,0.314026
All You Need to Know About VistaGen Therapeutics  ( VTGN )  Rating Upgrade to Buy,20240906T160010,https://www.zacks.com/stock/news/2333012/all-you-need-to-know-about-vistagen-therapeutics-vtgn-rating-upgrade-to-buy,VTGN,0.360752,Somewhat-Bullish,0.321131
"VistaGen Therapeutics, Inc.  ( VTGN )  Reports Q1 Loss, Lags Revenue Estimates",20240813T213006,https://www.zacks.com/stock/news/2321619/vistagen-therapeutics-inc-vtgn-reports-q1-loss-lags-revenue-estimates,VTGN,0.397098,Neutral,0.046334
"Seer, Inc.  ( SEER )  Reports Q2 Loss, Misses Revenue Estimates",20240808T222006,https://www.zacks.com/stock/news/2319624/seer-inc-seer-reports-q2-loss-misses-revenue-estimates,VTGN,0.208166,Neutral,0.0
"ADC Therapeutics SA  ( ADCT )  Reports Q2 Loss, Lags Revenue Estimates",20240806T124007,https://www.zacks.com/stock/news/2316762/adc-therapeutics-sa-adct-reports-q2-loss-lags-revenue-estimates,VTGN,0.207571,Neutral,0.0
This overlooked corner of women's health could be a $350 billion market opportunity,20240315T183339,https://www.cnbc.com/2024/03/15/this-overlooked-corner-of-womens-health-could-be-a-350-billion-market-opportunity.html,VTGN,0.0378,Somewhat-Bullish,0.180949
"Does VistaGen Therapeutics, Inc.  ( VTGN )  Have the Potential to Rally 160% as Wall Street Analysts Expect?",20240221T145508,https://www.zacks.com/stock/news/2229373/does-vistagen-therapeutics-inc-vtgn-have-the-potential-to-rally-160-as-wall-street-analysts-expect,VTGN,0.2842,Bullish,0.366274
Immunocore Holdings PLC Sponsored ADR  ( IMCR )  Moves 6.9% Higher: Will This Strength Last?,20240201T101600,https://www.zacks.com/stock/news/2219166/immunocore-holdings-plc-sponsored-adr-imcr-moves-69-higher-will-this-strength-last,VTGN,0.48028,Neutral,-0.078632
How Vistagen  ( VTGN )  Stock Stands Out in a Strong Industry,20231229T134000,https://www.zacks.com/stock/news/2203570/how-vistagen-vtgn-stock-stands-out-in-a-strong-industry,VTGN,0.495015,Bullish,0.501036
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",20231214T221500,https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,VTGN,0.078099,Neutral,0.0
"Undervalued VistaGen Therapeutics, Analyst Highlights Potential In Anxiety Treatment - Vistagen Therapeutics  ( NASDAQ:VTGN ) ",20231204T193915,https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36075808/undervalued-vistagen-therapeutics-analyst-highlights-potential-in-anxiety-treatment,VTGN,0.470894,Somewhat-Bearish,-0.207332
Anxiety-Focused Stock Vistagen Therapeutics Is An Undervalued Late-Stage Neurology Player: Analyst - Vistagen Therapeutics  ( NASDAQ:VTGN ) ,20231114T190802,https://www.benzinga.com/analyst-ratings/analyst-color/23/11/35784636/anxiety-focused-stock-vistagen-therapeutics-is-an-undervalued-late-stage-neurology-,VTGN,0.6338,Neutral,-0.099155
VistaGen Therapeutics' Robust Financial Position and Promising Pipeline Underpin Buy Rating: A Comprehensive Analysis,20231112T091612,https://markets.businessinsider.com/news/stocks/vistagen-therapeutics-robust-financial-position-and-promising-pipeline-underpin-buy-rating-a-comprehensive-analysis-1032809186,VTGN,0.445179,Neutral,-0.065464
"10 Short Squeeze Stocks To Watch: Getty Images, Bitcoin Depot, Blue Apron Holdings And More - Getty Images Holdings  ( NYSE:GETY ) ",20230911T145221,https://www.benzinga.com/markets/cryptocurrency/23/09/34441982/10-short-squeeze-stocks-to-watch-getty-images-bitcoin-depot-blue-apron-holdings-and-more,VTGN,0.12013,Neutral,-0.076265
"Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket - AppLovin  ( NASDAQ:APP ) , Amyris  ( NASDAQ:AMRS ) ",20230810T120627,https://www.benzinga.com/news/23/08/33704412/why-applovin-shares-are-trading-higher-by-over-22-here-are-20-stocks-moving-premarket,VTGN,0.231332,Neutral,0.075474
"$18M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying - Asana  ( NYSE:ASAN ) , CVB Financial  ( NASDAQ:CVBF ) ",20230810T105919,https://www.benzinga.com/trading-ideas/long-ideas/23/08/33701635/18m-bet-on-this-healthcare-stock-check-out-these-4-stocks-insiders-are-buying,VTGN,0.413199,Neutral,-0.005726
What's Going On With VistaGen Therapeutics Stock? - Vistagen Therapeutics  ( NASDAQ:VTGN ) ,20230808T133548,https://www.benzinga.com/news/23/08/33629526/whats-going-on-with-vistagen-therapeutics-stock,VTGN,0.397098,Neutral,0.111073
"VistaGen Therapeutics  ( VTGN Stock )  Exploded 3,471% Here's Why",20230807T135840,https://pennystocks.com/featured/2023/08/07/vistagen-therapeutics-vtgn-stock-exploded-3471-heres-why/,VTGN,0.260652,Neutral,0.092215
Dow Jumps 250 Points; Tyson Foods Posts Downbeat Results,20230807T135019,https://markets.businessinsider.com/news/stocks/dow-jumps-250-points-tyson-foods-posts-downbeat-results-1032524369,VTGN,0.062926,Neutral,0.121389
Why Is Vistagen Stock Going Over 1000% Today? - Vistagen Therapeutics  ( NASDAQ:VTGN ) ,20230807T133049,https://www.benzinga.com/general/biotech/23/08/33600552/vistagens-big-breakthrough-says-single-administration-of-nasal-spray-candidate-can-potentially-re,VTGN,0.431065,Somewhat-Bearish,-0.157773
"Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Bone Biologics  ( NASDAQ:BBLG ) , Fresh2 Group  ( NASDAQ:FRES ) ",20230621T114941,https://www.benzinga.com/trading-ideas/long-ideas/23/06/32943669/top-4-health-care-stocks-which-could-rescue-your-portfolio-this-month,VTGN,0.352223,Neutral,0.097169
Vistagen's Nasal Spray Shows Efficacy In Menopausal Hot Flashes - VistaGen Therapeutics  ( NASDAQ:VTGN ) ,20230607T171541,https://www.benzinga.com/general/biotech/23/06/32760252/vistagens-nasal-spray-shows-efficacy-in-menopausal-hot-flashes,VTGN,0.507932,Bullish,0.375526
"Why LL Flooring Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - AcelRx Pharmaceuticals  ( NASDAQ:ACRX ) , Aclarion  ( NASDAQ:ACON ) ",20230531T123927,https://www.benzinga.com/news/23/05/32645917/why-ll-flooring-shares-are-trading-higher-by-19-here-are-20-stocks-moving-premarket,VTGN,0.151539,Neutral,0.02044
Penny Stocks & The Stock Market Today: Top Trends & Stocks To Watch,20230530T222738,https://pennystocks.com/featured/2023/05/30/penny-stocks-the-stock-market-today-top-trends-stocks-to-watch/,VTGN,0.05492,Neutral,-0.10007
Why VistaGen Therapeutics Stock Is Trading Higher Today - VistaGen Therapeutics  ( NASDAQ:VTGN ) ,20230406T134049,https://www.benzinga.com/news/23/04/31697963/why-vistagen-therapeutics-stock-is-trading-higher-today,VTGN,0.612033,Neutral,-0.046842
"Why Alteryx Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Aeva Technologies  ( NYSE:AEVA ) , AppHarvest  ( NASDAQ:APPH ) ",20230210T133135,https://www.benzinga.com/news/23/02/30853869/why-alteryx-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket,VTGN,0.185306,Neutral,-0.004533
VistaGen Shares Plunge Amid Uncertainty Around Its Anxiety Trial - VistaGen Therapeutics  ( NASDAQ:VTGN ) ,20230208T174935,https://www.benzinga.com/general/biotech/23/02/30818268/vistagen-shares-plunge-amid-uncertainty-around-its-anxiety-trial,VTGN,0.521465,Neutral,0.003301
"Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket - Enphase Energy  ( NASDAQ:ENPH ) , Youdao  ( NYSE:DAO ) ",20230208T121742,https://www.benzinga.com/news/23/02/30805823/why-sintx-technologies-shares-are-trading-lower-by-38-here-are-20-stocks-moving-premarket,VTGN,0.139669,Somewhat-Bearish,-0.261556
"VistaGen Therapeutics, Inc.  ( VTGN )  Reports Q3 Loss, Misses Revenue Estimates",20230207T231506,https://www.zacks.com/stock/news/2051318/vistagen-therapeutics-inc-vtgn-reports-q3-loss-misses-revenue-estimates,VTGN,0.398148,Neutral,0.105847
3 Penny Stocks Under $1 To Watch This Week,20230111T192743,https://pennystocks.com/featured/2023/01/11/3-penny-stocks-under-1-to-watch-this-week-january-2023/,VTGN,0.041538,Somewhat-Bullish,0.16176
"Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket - Argo Blockchain  ( NASDAQ:ARBK ) , Ambrx Biopharma  ( NYSE:AMAM ) ",20221229T113621,https://www.benzinga.com/news/22/12/30224336/why-cal-maine-foods-shares-are-trading-lower-here-are-24-stocks-moving-premarket,VTGN,0.169279,Somewhat-Bullish,0.208473
Vistagen Strengthens Its Neurology Focused Pipeline With Pherin Pharma Acquisition - VistaGen Therapeutics  ( NASDAQ:VTGN ) ,20221221T155643,https://www.benzinga.com/general/biotech/22/12/30161391/vistagen-strengthens-its-neurology-focused-pipeline-with-pherin-pharma-acquisition,VTGN,0.595343,Bullish,0.563225
BioCryst  ( BCRX )  Down as it Discontinues Developing PNH Drug,20221216T171000,https://www.zacks.com/stock/news/2029696/biocryst-bcrx-down-as-it-discontinues-developing-pnh-drug,VTGN,0.182967,Neutral,-0.04265
Cytokinetics  ( CYTK )  Up Despite Unfavorable FDA Committee Voting,20221215T151200,https://www.zacks.com/stock/news/2029194/cytokinetics-cytk-up-despite-unfavorable-fda-committee-voting,VTGN,0.182047,Neutral,-0.045496
"Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical Officer - Bright Minds Biosciences  ( NASDAQ:DRUG ) ",20221123T163529,https://www.benzinga.com/pressreleases/22/11/g29842256/bright-minds-biosciences-appoints-drug-development-executive-mark-a-smith-m-d-ph-d-as-chief-medica,VTGN,0.040969,Neutral,-0.067624
"Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical Officer",20221123T163500,https://www.globenewswire.com/news-release/2022/11/23/2561793/0/en/Bright-Minds-Biosciences-Appoints-Drug-Development-Executive-Mark-A-Smith-M-D-Ph-D-as-Chief-Medical-Officer.html,VTGN,0.042723,Neutral,-0.067769
"What Makes VistaGen Therapeutics, Inc.  ( VTGN )  a New Buy Stock",20221115T170005,https://www.zacks.com/stock/news/2018539/what-makes-vistagen-therapeutics-inc-vtgn-a-new-buy-stock,VTGN,0.359014,Somewhat-Bullish,0.317771
"VistaGen Therapeutics, Inc.  ( VTGN )  Reports Q2 Loss, Misses Revenue Estimates",20221110T234509,https://www.zacks.com/stock/news/2017060/vistagen-therapeutics-inc-vtgn-reports-q2-loss-misses-revenue-estimates,VTGN,0.40348,Neutral,-0.00276
"Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket - AgriFORCE Growing Systems  ( NASDAQ:AGRI ) , AcelRx Pharmaceuticals  ( NASDAQ:ACRX ) ",20220921T101648,https://www.benzinga.com/news/22/09/28944466/why-ecmoho-is-trading-lower-by-29-here-are-28-stocks-moving-premarket,VTGN,0.121343,Somewhat-Bearish,-0.201001
"Chembio Diagnostics  ( NASDAQ:CEMI ) , Ayala Pharmaceuticals  ( NASDAQ:AYLA )  - Why Zumiez Is Trading Lower By 14%; Here Are 20 Stocks Moving Premarket",20220909T103544,https://www.benzinga.com/news/22/09/28807938/why-zumiez-is-trading-lower-by-14-here-are-20-stocks-moving-premarket,VTGN,0.235823,Neutral,-0.04023
Why Zumiez Is Trading Lower By 14%; Here Are 20 Stocks Moving Premarket,20220909T103544,https://markets.businessinsider.com/news/stocks/why-zumiez-is-trading-lower-by-14-here-are-20-stocks-moving-premarket-1031734321,VTGN,0.163354,Neutral,-0.029086
"Silence Therapeutics  ( NASDAQ:SLN ) , Alnylam Pharmaceuticals  ( NASDAQ:ALNY ) , Eli Lilly  ( NYSE:LLY ) , Amryt Pharma  ( NASDAQ:AMYT ) , SCYNEXIS  ( NASDAQ:SCYX ) , SINTX Technologies  ( NASDAQ:SINT ) , Ocuphire Pharma  ( NASDAQ:OCUP ) , Regeneron Pharmaceuticals  ( NASDAQ:REGN ) , VistaGen Therapeutics  ( NASDAQ:VTGN ) , Axsome Therapeutics  ( NASDAQ:AXSM ) , Lyra Therapeutics  ( NASDAQ:LYRA ) , Revance Therapeutics  ( NASDAQ:RVNC )  - Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary",20220908T221721,https://www.benzinga.com/general/biotech/22/09/28804732/important-biotech-catalysts-for-september-8-2022-end-of-the-day-summary,VTGN,0.088635,Neutral,-0.039079
VistaGen Therapeutics  ( NASDAQ:VTGN )  - Independent Biostatisticians Recommend Vistagen Continue Late-Stage Anxiety Trial,20220908T182448,https://www.benzinga.com/general/biotech/22/09/28800101/independent-biostatisticians-recommend-vistagen-continue-late-stage-anxiety-trial,VTGN,0.636698,Somewhat-Bearish,-0.290656
Hot Penny Stocks To Buy For Under $0.99 This Week,20220908T144058,https://pennystocks.com/featured/2022/09/08/hot-penny-stocks-to-buy-for-under-0-99-this-week/,VTGN,0.102303,Somewhat-Bullish,0.247475
IBIO: 3 Biotech Penny Stocks to Avoid,20220823T171130,https://stocknews.com/news/ibio-vtgn-tmbr-3-biotech-penny-stocks-to-avoid/,VTGN,0.2138,Neutral,-0.094292
Why Crypto-Related Stocks Are Trading Lower: Here Are 34 Stocks Moving Premarket,20220819T112410,https://www.benzinga.com/news/22/08/28564076/why-crypto-related-stocks-are-trading-lower-here-are-34-stocks-moving-premarket,VTGN,0.127007,Neutral,0.051248
"Adma Biologics  ( ADMA )  Reports Q2 Loss, Tops Revenue Estimates",20220810T212511,https://www.zacks.com/stock/news/1966890/adma-biologics-adma-reports-q2-loss-tops-revenue-estimates,VTGN,0.200688,Neutral,0.094462
"Beam Therapeutics Inc.  ( BEAM )  Reports Q2 Loss, Tops Revenue Estimates",20220809T114508,https://www.zacks.com/stock/news/1965808/beam-therapeutics-inc-beam-reports-q2-loss-tops-revenue-estimates,VTGN,0.201803,Neutral,0.118247
Why Vistagen Therapeutics Stock Is Falling,20220726T143646,https://www.benzinga.com/markets/penny-stocks/22/07/28206634/vistagen-therapeutics-shares-are-falling-sharply-heres-why,VTGN,0.822443,Neutral,-0.004107
Recap Of Friday's Biotech Catalysts - End Of The Day Summary,20220722T215911,https://www.benzinga.com/general/biotech/22/07/28176253/recap-of-fridays-biotech-catalysts-end-of-the-day-summary,VTGN,0.138464,Neutral,-0.036475
Dow Dips More Than 200 Points; Crude Oil Moves Lower,20220722T185928,https://www.benzinga.com/news/earnings/22/07/28174160/dow-dips-more-than-200-points-crude-oil-moves-lower,VTGN,0.148731,Somewhat-Bearish,-0.2303
Nasdaq Drops Around 200 Points; Hanger Shares Spike Higher,20220722T164959,https://www.benzinga.com/news/earnings/22/07/28172512/nasdaq-drops-around-200-points-hanger-shares-spike-higher,VTGN,0.150122,Somewhat-Bearish,-0.231544
VistaGen Reports Topline Results from PALISADE-1 Phase 3 Clinical Trial for PH94B | Financial Buzz,20220722T161039,https://www.financialbuzz.com/vistagen-reports-topline-results-from-palisade-1-phase-3-clinical-trial-for-ph94b/,VTGN,0.288893,Somewhat-Bearish,-0.196734
VistaGen Says Data From Late-Stage Anxiety Study 'Not Consistent' With Prior Positive Phase 2 Study,20220722T130657,https://www.benzinga.com/general/biotech/22/07/28167941/vistagen-says-data-from-late-stage-anxiety-study-not-consistent-with-prior-positive-phase-2-study,VTGN,0.532043,Somewhat-Bearish,-0.167233
"Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset",20220722T125344,https://www.benzinga.com/general/biotech/22/07/28168177/daily-biotech-pulse-vistagens-anxiety-study-fails-silverback-to-merge-with-firm-developing-epipen,VTGN,0.159043,Somewhat-Bearish,-0.237085
"VistaGen Therapeutics, Inc.  ( VTGN )  Reports Q4 Loss, Misses Revenue Estimates",20220623T213503,https://www.zacks.com/stock/news/1943174/vistagen-therapeutics-inc-vtgn-reports-q4-loss-misses-revenue-estimates,VTGN,0.423809,Neutral,-0.008368
Stocks That Hit 52-Week Lows On Friday,20220610T154524,https://www.benzinga.com/markets/options/22/06/27650434/52-weeks-high-and-low-article,VTGN,0.013393,Neutral,0.034856
"Nurix Therapeutics, Inc.  ( NRIX )  Soars 14.5%: Is Further Upside Left in the Stock?",20220531T092000,https://www.zacks.com/stock/news/1931581/nurix-therapeutics-inc-nrix-soars-145-is-further-upside-left-in-the-stock,VTGN,0.398306,Neutral,-0.04597
Stocks That Hit 52-Week Lows On Monday,20220523T161249,https://www.benzinga.com/markets/options/22/05/27350703/52-weeks-high-and-low-article,VTGN,0.037702,Neutral,-0.002739
Bristol Myers'  ( BMY )  Opdivo Data Positive for Neoadjuvant NSCLC,20220412T185700,https://www.zacks.com/stock/news/1898093/bristol-myers-bmy-opdivo-data-positive-for-neoadjuvant-nsclc,VTGN,0.15383,Neutral,-0.095927
Gilead  ( GILD )  Magrolimab Studies' Partial Clinical Hold Removed,20220412T152000,https://www.zacks.com/stock/news/1897942/gilead-gild-magrolimab-studies-partial-clinical-hold-removed,VTGN,0.194972,Neutral,-0.13229
Novartis  ( NVS )  Anti-PD-1 Drug Validated by EMA for Lung Cancer,20220407T160500,https://www.zacks.com/stock/news/1894957/novartis-nvs-anti-pd-1-drug-validated-by-ema-for-lung-cancer,VTGN,0.185259,Neutral,-0.147607
Bristol Myers  ( BMY )  Gets EC Nod for Opdivo's Label Expansion,20220405T160800,https://www.zacks.com/stock/news/1893289/bristol-myers-bmy-gets-ec-nod-for-opdivos-label-expansion,VTGN,0.158868,Neutral,-0.135022
